Royal Bank of Canada’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,775
| Closed | -$50K | – | 7359 |
|
|
2018
Q4 | $50K | Sell |
1,775
-806
| -31% | -$22.9K | ﹤0.01% | 5110 |
|
|
2018
Q3 | $72K | Sell |
2,581
-1,036
| -29% | -$29.1K | ﹤0.01% | 5050 |
|
|
2018
Q2 | $101K | Buy |
3,617
+548
| +18% | +$14.7K | ﹤0.01% | 4804 |
|
|
2018
Q1 | $77K | Sell |
3,069
-305
| -9% | -$7.42K | ﹤0.01% | 4841 |
|
|
2017
Q4 | $81K | Sell |
3,374
-6,045
| -64% | -$159K | ﹤0.01% | 4934 |
|
|
2017
Q3 | $261K | Buy |
9,419
+6,386
| +211% | +$170K | ﹤0.01% | 4314 |
|
|
2017
Q2 | $76K | Sell |
3,033
-5,783
| -66% | -$143K | ﹤0.01% | 4910 |
|
|
2017
Q1 | $236K | Sell |
8,816
-1,755
| -17% | -$48.5K | ﹤0.01% | 4239 |
|
|
2016
Q4 | $278K | Sell |
10,571
-14,638
| -58% | -$362K | ﹤0.01% | 4259 |
|
|
2016
Q3 | $630K | Sell |
25,209
-5,891
| -19% | -$137K | ﹤0.01% | 3518 |
|
|
2016
Q2 | $674K | Buy |
31,100
+22,870
| +278% | +$408K | ﹤0.01% | 3434 |
|
|
2016
Q1 | $124K | Sell |
8,230
-3,151
| -28% | -$52.8K | ﹤0.01% | 4651 |
|
|
2015
Q4 | $249K | Buy |
11,381
+5,088
| +81% | +$94.8K | ﹤0.01% | 4365 |
|
|
2015
Q3 | $99K | Sell |
6,293
-27,097
| -81% | -$434K | ﹤0.01% | 4781 |
|
|
2015
Q2 | $476K | Buy |
33,390
+31,140
| +1,384% | +$527K | ﹤0.01% | 3649 |
|
|
2015
Q1 | $39K | Sell |
2,250
-4,795
| -68% | -$84.7K | ﹤0.01% | 5091 |
|
|
2014
Q4 | $126K | Hold |
7,045
| – | – | ﹤0.01% | 4622 |
|
|
2014
Q3 | $93K | Buy |
7,045
+5,795
| +464% | +$78K | ﹤0.01% | 4663 |
|
|
2014
Q2 | $18K | Hold |
1,250
| – | – | ﹤0.01% | 5242 |
|
|
2014
Q1 | $16K | Sell |
1,250
-22,522
| -95% | -$294K | ﹤0.01% | 5286 |
|
|
2013
Q4 | $238K | Buy |
23,772
+8,489
| +56% | +$96.4K | ﹤0.01% | 4032 |
|
|
2013
Q3 | $201K | Buy |
15,283
+14,033
| +1,123% | +$184K | ﹤0.01% | 4085 |
|
|
2013
Q2 | $18K | Buy |
+1,250
| New | +$15.7K | ﹤0.01% | 5077 |
|
Other funds holding NXTM
Royal Bank of Canada's NXTM Position: Q1 2019 in Review
Royal Bank of Canada sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,775 shares — an estimated $50K sold.
Royal Bank of Canada first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $674K in Q2 2016. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Royal Bank of Canada reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Royal Bank of Canada sold 1,775 NxStage Medical Inc. shares in Q1 2019, an estimated $50K.
- Royal Bank of Canada first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- Royal Bank of Canada's NxStage Medical Inc. position peaked at $674K in Q2 2016.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Royal Bank of Canada's 13F filing for Q1 2019, filed 15 May 2019.